HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Claveau-Tremblay, R. Articles by Leblond, R. Search for Related Content PubMed PubMed Citation Articles by Claveau-Tremblay, R. Articles by Leblond, R.

False-Positive Captopril Renography in Patients Taking Calcium Antagonists

Nuclear Medicine Department, Complexe Hospitalier de la Sagamie, Chicoutimi
Nuclear Medicine Department, Hôtel-Dieu de Montréal, Montréal
Epidemiologie Genetics, Université du Québec à Chicoutimi and Unité de Recherches Cliniques, Complexe Hospitalier de la Sagamie, Chicoutimi, Québec, Canada

Correspondence: For correspondence or reprints contact: Rosaire Claveau-Tremblay, MD, Nuclear Medicine Department, Complexe HOspitalier de la Sagamie, 305 St-Vallier, Chicoutimi, Québec, Canada G7H 5H6.

ABSTRACT

Captopril-enhanced renography is the noninvasive test of choice for the diagnosis of renovascular hypertension. Previous studies have shown that bilateral symmetrical changes are assodated with many renal conditions. However, patients with normal renal angiography occurred in our institutions despite this scintigraphic pattern, and no known conditions could explain these results. The purpose of this study was to evaluate the diagnostic implications of bilateral symmetrical renal function deterioration on captopril renography. Methodes: Eighty-six captopril renal scintigraphies performed at two centers to exclude renovascular hypertension (50 consecutive patients after the observation of a bilateral symmetrical renal function deterioration despite a normal angiogram at one institution and 36 patients with both captopril renography and renal angiography at the other institution) were retrospectively reviewed. Baseline and captopril-enhanced renograms were obtained with ^99mTc-mercaptoacetyltriglycine and a 1-day protocol in 50 patients; 36 patients were studied using ^99mTc-diethylenetriamine pentaacetic acid and a 2-day protocol. Bilateral symmetrical renal function deterioration was detected. Results: Ten patients presented with bilateral symmetrical renal function deterioration on their captopril renograms; 9 of them were taking calcium antagonists (p = 0.015). Control studies performed in 5 patients without these medications demonstrated normal captopril renograms in 4 and persistant renal dysfunction in 1. No explanation was found for the patient who was not taking any medication. Angiograms performed in 5 patients showed normal renal arteries. An 11th patient who was taking a calcium antagonist showed dysfunction of his one kidney on the captopril renogram but no artery stenosis on the renal angiogram. Conclusion: Calcium antagonists can cause false-positive captopril renograms. These medications should be stopped before captopril renography, and physicians should be aware of this possible drug interaction if bilateral symmetrical renal function deterioration is seen on a patient's captopril renogram.

Key Words: angiotensin-converting enzyme inhibitor • renography • renovascular hypertension

This article has been cited by other articles:

				G. Picciotto, A. Sargiotto, M. Petrarulo, C. Rabbia, P. G. De Filippi, and D. Roccatello Reliability of Captopril Renography in Patients Under Chronic Therapy with Angiotensin II (AT1) Receptor Antagonists J. Nucl. Med., October 1, 2003; 44(10): 1574 - 1581. [Abstract] [Full Text] [PDF]